세계의 실행증 시장 보고서(2025년)
Apraxia Global Market Report 2025
상품코드 : 1720714
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,482,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,370,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,257,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

실행증 시장 규모는 향후 수년간 강력한 성장이 예상될 예정입니다. 예측 기간의 성장은 치료에 대한 보험 적용 범위의 확대 등에 있다고 볼 수 있습니다. 이 기간의 주요 동향에는 AI를 활용한 음성 치료 앱, 웨어러블 신경 자극 장치, 영상 진단의 진보, 개별화 재활 프로그램, 원격 치료 플랫폼, 브레인 컴퓨터 인터페이스, 신규 약리학적 치료의 개발 등이 있습니다.

신경질환의 유병률 증가는 향후 몇 년간의 실행증 시장의 성장을 가속할 것으로 예측됩니다. 이러한 질환의 발생률 상승에 기여하고 있습니다.실행증은 뇌기능장애, 특히 운동의 계획이나 조정을 담당하는 부위의 기능장애를 나타내는 중요한 지표가 되어, 신경질환의 진단이나 치료에 빠뜨릴 수 없는 것으로 되어 있습니다. 예를 들어, 2022년 4월 벨기에에 본부를 둔 비영리 단체인 유럽뇌협회는 600여 가지의 신경 질환과 300여 가지의 정신과 질환이 6,500만 명의 뇌전증 환자를 포함해 전 세계 수백만 명에게 영향을 미친다고 보고했습니다. 유럽에서만 1,050만 명이 치매를 앓고 있으며, 2050년에는 1,870만 명으로 늘어날 것으로 예상됩니다. 그 결과, 신경질환 증가가 실행증 시장의 확대에 박차를 가하고 있습니다.

실행증 시장에서 사업을 전개하는 기업은 연구 활동의 강화, 치료 선택의 확대, 환자 케어의 개선을 목적으로 한 전략적 제휴에 임하고 있습니다. 이 이니셔티브는 아동기 실어증(CAS) 및 기타 심각한 언어 장애를 겪는 5세에서 7세 사이의 어린이를 돕기 위해 마련되었습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

KTH
영문 목차

영문목차

Apraxia is a neurological disorder that impairs purposeful movements despite normal muscle strength, coordination, and comprehension. It is caused by brain damage, often affecting motor planning areas such as the parietal or frontal lobes. Individuals with apraxia may have difficulty performing tasks such as waving, tying shoelaces, or speaking.

The primary types of apraxia include ideomotor apraxia, ideational or conceptual apraxia, buccofacial or orofacial apraxia, constructional apraxia, gait apraxia, limb-kinetic apraxia, oculomotor apraxia, and apraxia of speech. Ideomotor apraxia is marked by difficulty executing voluntary movements or actions, even when the individual understands the task and has the physical capability to perform it. Treatment options for apraxia include speech therapy, occupational therapy, and physical therapy. Diagnosis typically involves assessments for upper limb apraxia, magnetic resonance imaging (MRI), and other tests.

The apraxia market research report is one of a series of new reports from The Business Research Company that provides apraxia market statistics, including the apraxia industry's global market size, regional shares, competitors with a apraxia market share, detailed apraxia market segments, market trends and opportunities, and any further data you may need to thrive in the apraxia industry. This apraxia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The apraxia market size has grown strongly in recent years. It will grow from $2.33 billion in 2024 to $2.49 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth during the historic period can be attributed to increasing awareness of apraxia in both children and adults, a rising prevalence of neurological disorders, improved access to healthcare and therapies, greater funding for neurological research, and the expansion of speech-language pathology programs.

The apraxia market size is expected to see strong growth in the next few years. It will grow to $3.22 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period is expected to be driven by the increasing adoption of advanced diagnostic tools, the expansion of teletherapy services, rising government initiatives for early diagnosis, a growing focus on personalized therapy solutions, and broader insurance coverage for therapies. Key trends during this period include AI-driven speech therapy apps, wearable neurostimulation devices, advancements in diagnostic imaging, personalized rehabilitation programs, teletherapy platforms, brain-computer interfaces, and the development of novel pharmacological treatments.

The increasing prevalence of neurological disorders is expected to drive the growth of the apraxia market in the coming years. Neurological disorders affect the brain, spinal cord, and nerves, leading to various impairments such as cognitive, motor, sensory, and behavioral dysfunctions. Several factors, including an aging population, increased awareness, and changing lifestyles, contribute to the rising incidence of these conditions. Apraxia serves as a crucial indicator of brain function impairment, particularly in regions responsible for planning and coordinating movements, making it essential for diagnosing and treating neurological disorders. For example, in April 2022, the European Brain Council, a Belgium-based non-profit organization, reported that more than 600 neurological diseases and nearly 300 psychiatric conditions impact millions worldwide, including 65 million individuals with epilepsy. In Europe alone, 10.5 million people are living with dementia, with projections estimating an increase to 18.7 million by 2050. As a result, the growing number of neurological disorders is fueling the expansion of the apraxia market.

Companies operating in the apraxia market are engaging in strategic collaborations to enhance research efforts, broaden treatment options, and improve patient care. In July 2024, Trios Health, a US-based healthcare company, partnered with Washington State University's Department of Speech and Hearing Sciences to introduce a specialized program called "Camp I Can Say It!". This initiative is designed to assist children between the ages of 5 and 7 who experience childhood apraxia of speech (CAS) and other severe speech disorders. The camp provides bilingual speech therapy for both English- and Spanish-speaking children and integrates early literacy development, offering a well-rounded approach to enhancing communication and academic skills.

In July 2022, ArchiMed SAS, a France-based investment company specializing in healthcare industries, acquired Natus Medical Incorporated for $1.1 billion. This acquisition aims to strengthen ArchiMed SAS's position in the neurodiagnostic device market while leveraging Natus' expertise and product offerings to drive innovation. Natus Medical Incorporated, a US-based company, specializes in medical devices and services focused on newborn care, neurology, sleep disorders, hearing, and balance assessment. This acquisition is expected to foster growth and advancement in the neurodiagnostic sector.

Major players in the apraxia market are Creative Expression Therapy (CET), North Shore Pediatric Therapy, Meredith Brand Therapy LLC, Chicago Speech Therapy, Expressable, Lingraphica, Instrumental Speech Language Pathology (Instrumental SLP), Voz Speech Therapy, Kaufman Children's Center, Chatterboxes Speech-Language & Occupational Therapy, TalkTools, Speech Therapy Centres of Canada, Speak Live Play, Northeast Hearing & Speech, The Center for Speech, Language, Occupational Therapy and Applied Behavior Analysis, Speech Bee, Dynamic Speech Therapy, A Mile High Speech Therapy, Tactus Therapy Solutions, and Con Moto Speech Services.

North America was the largest region in the apraxia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in apraxia report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the apraxia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The apraxia market includes revenues earned by providing services such as speech therapy, diagnostic assessments, and therapeutic services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Apraxia Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on apraxia market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for apraxia ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The apraxia market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Apraxia Market Characteristics

3. Apraxia Market Trends And Strategies

4. Apraxia Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Apraxia Growth Analysis And Strategic Analysis Framework

6. Apraxia Market Segmentation

7. Apraxia Market Regional And Country Analysis

8. Asia-Pacific Apraxia Market

9. China Apraxia Market

10. India Apraxia Market

11. Japan Apraxia Market

12. Australia Apraxia Market

13. Indonesia Apraxia Market

14. South Korea Apraxia Market

15. Western Europe Apraxia Market

16. UK Apraxia Market

17. Germany Apraxia Market

18. France Apraxia Market

19. Italy Apraxia Market

20. Spain Apraxia Market

21. Eastern Europe Apraxia Market

22. Russia Apraxia Market

23. North America Apraxia Market

24. USA Apraxia Market

25. Canada Apraxia Market

26. South America Apraxia Market

27. Brazil Apraxia Market

28. Middle East Apraxia Market

29. Africa Apraxia Market

30. Apraxia Market Competitive Landscape And Company Profiles

31. Apraxia Market Other Major And Innovative Companies

32. Global Apraxia Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Apraxia Market

34. Recent Developments In The Apraxia Market

35. Apraxia Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기